The Global Automated
Endoscopy Reprocessor Market, by Product Type (Single Basin and Double
Basin), by Modality (Portable and Standalone), by End User (Hospital,
Diagnostic Laboratories, and Ambulatory Centers), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$
845.3 million in 2017 and is projected to exhibit a CAGR of 6.7% over the
forecast period (2018 – 2026). Automated endoscopy reprocessor (AER) market is
expected to grow at significant rate, owing to rising number of
gastrointestinal (GI) diseases demanding endoscopy procedures.
Increasing demand for endoscopic
devices is expected to drive the automated endoscopy reprocessor market growth
Various factors such as rising
cases of stomach ulcers, increasing alcohol consumption, lack of proper diet
and increasing incidence of autoimmune diseases are contributing to the rise of
GI disorders worldwide. Common GI diseases include colorectal cancer,
ulcerative colitis, gastro esophageal reflux disease, Crohn’s disease, and
inflammatory bowel disease.
Emerging nations are experiencing
remarkably high demand for minimally invasive surgical procedures due to
increasing disease burden and rising disposable income. However, lack of
healthcare professionals skilled in endoscopic procedures and lack of proper
medical equipment has created an imbalance between demand and supply. Moreover,
a sturdy rise is observed every year in demand for endoscopy in all modern
healthcare systems. According to International Journal of Gastroenterology
Disorders & Therapy article 2015, about 30 million endoscopic procedures
are performed annually in the U.S. Endoscopic products manufacturers are using
their technology and services to fulfil this growing demand.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1916
Automated endoscopy reprocessor
offer many advantages over manual reprocessing such as automation and
standardization of several important reprocessing steps, thus eliminating the
chance of missing steps owing to human error, and lessen exposure of endoscopy
or sterile processing department personnel to high-level disinfectants (HLDs)
or chemical sterilants. Therefore, demand for these products is increasing
significantly.
Browse 35 Market Data Tables and
28 Figures spread through 180 Pages and in-depth TOC on “Automated Endoscopy
Reprocessor Market, by Product Type (Single Basin and Double Basin), by
Modality (Portable and Standalone), by End User (Hospital, Diagnostic
Laboratories, and Ambulatory Centers), and by Region (North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026”
Key players in automated
endoscopy reprocessor market are investing significantly in new product
development and innovations in existing products, and focus on strategic
collaboration to enhance their market share. For instance, in April 2018,
Cantel Medical received FDA approval to sell its new automated endoscope
reprocessor, Advantage Plus Pass-Thru. The device provides high-level
disinfection for commonly used endoscopes, including duodenoscopes.
Furthermore, in 2014, Cantel
Medical Corp. acquired PuriCore International Ltd., a provider of automated
endoscope reprocessors, endoscope drying and storage cabinets, chemistry and
consumables for US$ 26.9 million. Moreover, collaborations among manufacturers,
accrediting organizations, healthcare providers, professionals, and government
organizations can help resolve problems associated with risk of infection
transmission, endoscope and AER design, and other issues related to endoscope
reprocessing.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/automated-endoscopy-reprocessor-market-1916
Key Takeaways of the Automated
Endoscopy Reprocessor Market:
The global automated endoscopy reprocessor
market size is expected to exhibit a CAGR of 6.7% over the forecast period,
owing to rising number gastrointestinal diseases demanding endoscopy
procedures.
Among modality, the standalone
segment is estimated to hold the dominant position in the automated endoscopy
reprocessor market, in 2017. This is due to large capacity of the machine in
comparison to portable product and therefore, demand for these products is
relatively high.
Among end user, the hospital
segment is estimated to hold the dominant position in the automated endoscopy
reprocessor market, in 2017, owing to increasing demand from hospitals for
endoscopy procedures.
North America holds a dominant
position in the global automated endoscopy reprocessor market, owing to
increase in R&D process and affordability among various organizations.
Key players operating in the
global automated endoscopy reprocessor market include Cantel Medical Corp.,
Johnson & Johnson, Laboratoires Anios, Olympus Corporation, Steelco SpA,
Steris Plc., Getinge Group, Hoya Group, and Metall Zug AG.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1916
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment